Results
The mean age of the patients was 61.1 (43-78) years. Mean duration of
the symptoms was 3.4 (0-9) months. The average plaque size before
treatment was 13.6 mm (7.1-16.8) and after treatment, this value
decreased to 10.8 mm (4.3-14.6) (p:0.025). The average scores of
Peyronie’s Disease Questionnaire elements; symptom severity, penile pain
and bother/discomfort were 12.3, 19.1 and 6.2, respectively before the
treatment. These scores were decreased to 8.9, 9.6 and 4.4, respectively
after treatment. All subgroups of Peyronie’s Disease Questionnaire
scores were significantly improved after treatment (p:0.001,
p<0.001, p:0.045, respectively). No adverse events were
observed during or after treatment.